Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesEndocrinologyCapital Bluecross CGM Prior Auth & Coverage | Open…
    Ask Trek AI about this page
    CurrentCapital BluecrossPolicy N/A

    Continuous Glucose Monitors (CGMs) — Prior Authorization and Benefit Limits

    Customize your policy alerts

    Sign up for all Capital Bluecross policy alerts

    Know when Capital Bluecross releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Governs prior authorization criteria and member benefit limits for Continuous Glucose Monitors (receivers, transmitters, sensors, readers/monitors) and associated NDC/GPI lists for Capital Bluecross members in NC.

    Policy Summary
    PayerCapital Bluecross
    PolicyContinuous Glucose Monitors (CGMs) — Prior Authorization and Benefit Limits
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionSubmit prior authorization showing the requested quantity is within program limits or include clinical justification for higher quantities.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    1/365dtypical receiver benefit limit
    1/90-365dtransmitter replacement frequency

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    4/28d
    sensor supply (common)
    Multipleproduct codes listed

    Coverage and Prior Authorization Criteria

    Prior Authorization Quantity Criteria

    Covered when ONE of the following is met:

    Quantity within limit OR justification: A. The requested quantity (dose) does NOT exceed the program quantity limit OR B. Information has been provided in support of therapy with a higher quantitysee product-specific limits (receivers: 1/365 days; transmitters: 1/90-365 days; sensors: 3-5 per 28-30 days)

    Approval length determined by prescriber's anticipated course of therapy unless superseded by source limits

    This policy governs prior authorization and member benefit limits for continuous glucose monitoring systems (CGMs) and their components. It does not list explicit clinical exclusions; instead, the document focuses on benefit limits for device components (receivers/monitors, transmitters, sensors) and enumerates the applicable product identifiers (NDCs and GPIs) used to determine coverage and quantity limits.

    Prior authorization determinations hinge on quantity limits. If a requested quantity exceeds the program benefit limit, the provider must supply clinical information supporting the need for a higher quantity. Requests that exceed the program quantity limits without such supporting information are at risk for denial.

    Product Codes, NDCs, GPIs and Benefit Limits

    Example covered NDCs (partial list shown in document)NDCCovered
    08627-0091-**NDC listed for Dexcom components (as provided)
    08627-0016-**NDC listed for Dexcom components (as provided)
    08627-0053-**NDC listed for Dexcom components (as provided)
    08627-0078-01NDC listed for Dexcom G7 receiver
    08627-0077-01NDC listed for Dexcom G7 sensor
    76300-0008-05NDC listed
    57599-0000-21NDC listed
    57599-0002-**NDC listed
    57599-0000-19NDC listed
    57599-0001-**NDC listed
    1–10 of 13
    1/2
    GPIsmixed
    97202012026200GPI listed for CGM components
    97202012066300GPI listed for CGM components
    97202012046300GPI listed for CGM components
    Additional covered NDCsNDCCovered
    76300-0239-82NDC listed (Guardian/Minimed family)
    76300-0100-01NDC listed
    43169-0704-05NDC listed
    63000-0179-62NDC listed
    76300-0100-02NDC listed
    76300-0179-62NDC listed
    76300-0725-01NDC listed
    43169-0800-40NDC listed
    76300-7701-01NDC listed
    63000-0413-38NDC listed
    1–10 of 13
    1/2
    Benefit Limit Criteria NDCNDCCovered
    63000-0956-40NDC listed under Benefit Limit Criteria
    inv-08: Receiver replacement interval
    Replacement interval1 receiver per 365 days
    Program noteBenefit limits apply to all listed MSC (MultiSource Code) products
    Member-friendly wording1 receiver / 365 days (Member Friendly Benefit Limit)
    inv-09: Transmitter replacement interval
    Replacement interval (product dependent)1 transmitter per 90–365 days (varies by product)
    Common program entrySome entries list 1 transmitter / 365 days while others list 1 transmitter / 90 days (product-specific)
    Member-friendly wording

    Provider Requirements and Authorization Process

    Prior Authorization

    Quantity-based prior authorization requirement

    Prior authorization will be approved only if the requested quantity does not exceed the program quantity limit or the request includes clinical information supporting therapy with a higher quantity; approval length is based on the prescriber's anticipated course of therapy unless superseded by source limits.

    • Program quantity limits (example): 1 receiver / 365 days; 1 transmitter / 90 days; 3–5 sensors per 28–30 days (product-specific).
    Step Therapy

    Step therapy not specified

    The policy does not specify a required step-therapy sequence or prior trial of another product before authorization; no explicit step therapy language is stated.

    Background on Continuous Glucose Monitoring Systems

    Continuous glucose monitoring systems consist of three primary components: a receiver/monitor (device for displaying CGM data), a transmitter (sends sensor data to the receiver), and disposable sensors (adhesive glucose sensing elements). The policy specifies device-specific supply limits: 1 receiver/monitor per 365 days, transmitters vary by product with common intervals of 1 per 90–365 days, and sensors are limited by product to typically 3–5 sensors per 28–30 days (many systems use 4 sensors/28 days). These component limits are applied against the NDC/GPI lists in the policy when evaluating prior authorization requests.

    Device Component Definitions

    inv-16: Receiver/Monitor
    DefinitionReceiver/Monitor: device component for displaying CGM data (receiver/monitor/reader)
    Typical benefit limit1 receiver/monitor per 365 days (System Setup and Member Friendly Benefit Limit entries list 1 per 365 days)
    Member wordingMember Friendly Benefit Limit: 1 reader / 365 days or 1 monitor / 365 days in various product entries
    inv-17: Transmitter
    DefinitionTransmitter: device component that sends sensor data to the receiver/monitor
    Typical benefit limitsCommonly 1 transmitter per 365 days; some products specify 1 transmitter per 90 days
    Policy Summary
    PayerCapital Bluecross
    PolicyContinuous Glucose Monitors (CGMs) — Prior Authorization and Benefit Limits
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionSubmit prior authorization showing the requested quantity is within program limits or include clinical justification for higher quantities.
    SourceLink
    On This Page
    Coverage and Prior Authorization CriteriaProduct Codes, NDCs, GPIs and Benefit LimitsProvider Requirements and Authorization ProcessBackground on Continuous Glucose Monitoring SystemsDevice Component Definitions
    Member Friendly Benefit Limit commonly shows 1 transmitter / 90 days or 1 transmitter / 365 days depending on product
    inv-10: Sensor supply
    Supply frequency (typical)3–5 sensors per 28–30 days (commonly 4 sensors / 28 days)
    Product variationSome products list 3 sensors / 30 days or 5 sensors / 30 days as applicable
    Member-friendly wordingMember Friendly Benefit Limit examples: 4 sensors / 28 days; 3 sensors / 30 days; 5 sensors / 30 days
    Documentation Required

    Required documentation for quantity

    Providers must document that the requested quantity is within the program quantity limit or must provide clinical justification/supporting information when requesting quantities above the program limit; reference product-specific NDC/GPI and benefit limits when documenting.

    • Reference NDCs/GPIs and the program limits listed in the policy (e.g., receivers, transmitters, sensors) when submitting justification.
    • Include clinical rationale explaining why standard quantity limits are insufficient for the member.
    Denial Risk

    Quantity over program limit without justification

    Requests that exceed the program quantity limit without submitted clinical justification may be denied as not meeting the authorization criteria.

    • Example program limits from the policy: 1 receiver per 365 days; 1 transmitter per 90 days; 4 sensors per 28 days (product-dependent).
    Program note
    Benefit limits are product-specific and apply to all listed MSC products
    inv-18: Sensor
    DefinitionSensor: disposable glucose sensor applied to the patient for continuous glucose monitoring
    Common benefit limits3–5 sensors per 28–30 days depending on product (commonly 4 sensors / 28 days)
    Member wordingMember Friendly Benefit Limit examples include 4 sensors / 28 days, 3 sensors / 30 days, and 5 sensors / 30 days